361 related articles for article (PubMed ID: 11089976)
21. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
22. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
[TBL] [Abstract][Full Text] [Related]
23. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
25. Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression.
Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A
Anticancer Res; 2003; 23(5b):4121-5. PubMed ID: 14666612
[TBL] [Abstract][Full Text] [Related]
26. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.
Jeon JH; Lee KN; Hwang CY; Kwon KS; You KH; Choi I
Cancer Res; 2005 Jun; 65(11):4485-9. PubMed ID: 15930262
[TBL] [Abstract][Full Text] [Related]
27. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.
Berg JP; Zhou Q; Breuhahn K; Schirmacher P; Patil MA; Chen X; Schäfer N; Höller TT; Fischer HP; Büttner R; Gütgemann I
Hum Pathol; 2007 Nov; 38(11):1621-7. PubMed ID: 17651785
[TBL] [Abstract][Full Text] [Related]
28. The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.
Emberley ED; Niu Y; Curtis L; Troup S; Mandal SK; Myers JN; Gibson SB; Murphy LC; Watson PH
Cancer Res; 2005 Jul; 65(13):5696-702. PubMed ID: 15994944
[TBL] [Abstract][Full Text] [Related]
29. Macrophage migration inhibitory factor does not modulate co-activation of androgen receptor by Jab1/CSN5.
Berndt K; Kim M; Meinhardt A; Klug J
Mol Cell Biochem; 2008 Jan; 307(1-2):265-71. PubMed ID: 17786542
[TBL] [Abstract][Full Text] [Related]
30. Receptor binding and cellular uptake studies of macrophage migration inhibitory factor (MIF): use of biologically active labeled MIF derivatives.
Kleemann R; Grell M; Mischke R; Zimmermann G; Bernhagen J
J Interferon Cytokine Res; 2002 Mar; 22(3):351-63. PubMed ID: 12034043
[TBL] [Abstract][Full Text] [Related]
31. Structural characterization of As-MIF and hJAB1 during the inhibition of cell-cycle regulation.
Park YH; Jeong MS; Ha KT; Yu HS; Jang SB
BMB Rep; 2017 May; 50(5):269-274. PubMed ID: 28366190
[TBL] [Abstract][Full Text] [Related]
32. Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma.
Rassidakis GZ; Claret FX; Lai R; Zhang Q; Sarris AH; McDonnell TJ; Medeiros LJ
Clin Cancer Res; 2003 Mar; 9(3):1121-8. PubMed ID: 12631617
[TBL] [Abstract][Full Text] [Related]
33. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.
Tomoda K; Kubota Y; Arata Y; Mori S; Maeda M; Tanaka T; Yoshida M; Yoneda-Kato N; Kato JY
J Biol Chem; 2002 Jan; 277(3):2302-10. PubMed ID: 11704659
[TBL] [Abstract][Full Text] [Related]
34. A 16-residue peptide fragment of macrophage migration inhibitory factor, MIF-(50-65), exhibits redox activity and has MIF-like biological functions.
Nguyen MT; Beck J; Lue H; Fünfzig H; Kleemann R; Koolwijk P; Kapurniotu A; Bernhagen J
J Biol Chem; 2003 Sep; 278(36):33654-71. PubMed ID: 12796500
[TBL] [Abstract][Full Text] [Related]
35. JAB1/CSN5 and the COP9 signalosome. A complex situation.
Chamovitz DA; Segal D
EMBO Rep; 2001 Feb; 2(2):96-101. PubMed ID: 11258719
[TBL] [Abstract][Full Text] [Related]
36. Jab1 interacts with brain-specific kinase 2 (BRSK2) and promotes its degradation in the ubiquitin-proteasome pathway.
Zhou J; Wan B; Li R; Gu X; Zhong Z; Wang Y; Yu L
Biochem Biophys Res Commun; 2012 Jun; 422(4):647-52. PubMed ID: 22609399
[TBL] [Abstract][Full Text] [Related]
37. Jab1 co-activation of c-Jun is abrogated by the serine 10-phosphorylated form of p27Kip1.
Chopra S; Fernandez De Mattos S; Lam EW; Mann DJ
J Biol Chem; 2002 Sep; 277(36):32413-6. PubMed ID: 12119282
[TBL] [Abstract][Full Text] [Related]
38. Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1).
Caballero OL; Resto V; Patturajan M; Meerzaman D; Guo MZ; Engles J; Yochem R; Ratovitski E; Sidransky D; Jen J
Oncogene; 2002 May; 21(19):3003-10. PubMed ID: 12082530
[TBL] [Abstract][Full Text] [Related]
39. COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK.
Naumann M; Bech-Otschir D; Huang X; Ferrell K; Dubiel W
J Biol Chem; 1999 Dec; 274(50):35297-300. PubMed ID: 10585392
[TBL] [Abstract][Full Text] [Related]
40. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression.
Tomoda K; Kato JY; Tatsumi E; Takahashi T; Matsuo Y; Yoneda-Kato N
Blood; 2005 Jan; 105(2):775-83. PubMed ID: 15353483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]